Given the heterogeneity in expression of CXCR4 found routinely within individual tumor samples (as we found, for example, in ACC metastases), depending on a number of factors such as scoring criteria, our array data may have contained a higher frequency of “negative” scores as compared to surveys using significantly larger tissue sections for individual cancers. This evidence concerns the gene CXCR4 and neoplasm.